News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Seattle Biotech Alder Biopharmaceuticals Inc. Files For A $115 Million IPO


3/19/2014 8:32:41 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Alder BioPharmaceuticals, a biotech developing antibodies to treat migraines and arthritis, filed on Wednesday with the SEC to raise up to $115 million in an initial public offering. The Bothell, WA-based company, which was founded in 2002 and booked $19 million in collaboration and licensing revenue for the fiscal year ended December 31, 2013, plans to list on the NASDAQ under the symbol ALDR. Alder BioPharmaceuticals initially filed confidentially on February 10, 2014.

Help employers find you! Check out all the jobs and post your resume.

Read at Nasdaq
Read at Wall Street Journal
Read at Street Insider
Read at Seattle Times


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES